indirubin has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhat, A; Bollareddy, SR; Dasari, D; Dhar, A; Goyal, S; Kalra, J; Krishna, V; Mangali, S; Sriram, D; Udumula, MP | 1 |
| Bhat, A; Dhar, A; Dhar, I; Kalra, J; Mangali, S; Sriram, D; Udumula, MP | 1 |
2 other study(ies) available for indirubin and Alloxan Diabetes
| Article | Year |
|---|---|
High fructose and streptozotocin induced diabetic impairments are mitigated by Indirubin-3-hydrazone via downregulation of PKR pathway in Wistar rats.
Topics: Adipose Tissue; Animals; Apoptosis; Diabetes Mellitus, Experimental; eIF-2 Kinase; Energy Metabolism; Fibrosis; Fructose; Indoles; MAP Kinase Signaling System; Muscle, Skeletal; Oxidative Stress; Pancreas; Rats; Rats, Wistar; Signal Transduction; Streptozocin | 2021 |
Pharmacological evaluation of novel PKR inhibitor indirubin-3-hydrazone in-vitro in cardiac myocytes and in-vivo in wistar rats.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cells, Cultured; Diabetes Mellitus, Experimental; eIF-2 Kinase; Hydrazones; Hyperglycemia; In Vitro Techniques; Indoles; Male; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Signal Transduction | 2018 |